Mark Heinen - 12 Sep 2022 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Head of Finance and Interim Chief Financial Officer
Signature
/s/ Mark Heinen
Issuer symbol
BTTX on OTC
Transactions as of
12 Sep 2022
Net transactions value
+$97,000
Form type
4
Filing time
14 Sep 2022, 16:37:42 UTC
Previous filing
28 Jun 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $46,304 +23,868 +119% $1.94 43,868 12 Sep 2022 Direct
transaction BTTX Common Stock Purchase $50,696 +26,132 +60% $1.94 70,000 13 Sep 2022 Direct
holding BTTX Common Stock 2,281 12 Sep 2022 By daughter
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Head of Finance and Interim Chief Financial Officer